Predictive Oncology Inc. — Director's Dealing 2016

Apr 20, 2016

SEC Form 4/A — Form 4/A

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2016-04-06

Reporting Person: Kornberg Joshua (Director, CEO and President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-06	Common Stock, $.01 par value	C	11112	—	Acquired	18073	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-06	Series B Convertible Preferred Stock	$	C	11112	Acquired		Common Stock, $.01 par value (11112)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $.01 par value	805982	Indirect
Common Stock, $.01 par value	615281	Indirect

Footnotes

F1: A limited liability company of which the Reporting Person is one of the managers. The Reporting Person disclaims beneficial ownership of such shares, except for those as to which he may have a pecuniary interest therein.

F2: A limited liability company, of which the Reporting Person is a member. The Reporting Person disclaims beneficial ownership of such shares, except for those as to which he may have a pecuniary interest therein.

F3: Conversion of Series B Preferred Stock into shares of Common Stock on a one-for-one basis, pursuant to the terms of the Series B Preferred Stock. The transaction is exempt under Rule 16b-6(b).

F4: No expiration date.